These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 23684658

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.
    Nour SA, Abdelmalak NS, Naguib MJ, Rashed HM, Ibrahim AB.
    Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.
    Seju U, Kumar A, Sawant KK.
    Acta Biomater; 2011 Dec; 7(12):4169-76. PubMed ID: 21839863
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles.
    Baltzley S, Mohammad A, Malkawi AH, Al-Ghananeem AM.
    AAPS PharmSciTech; 2014 Dec; 15(6):1598-602. PubMed ID: 25142821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
    Qureshi M, Aqil M, Imam SS, Ahad A, Sultana Y.
    Curr Drug Deliv; 2019 Dec; 16(2):123-135. PubMed ID: 30317997
    [Abstract] [Full Text] [Related]

  • 11. Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.
    Rashed HM, Shamma RN, Basalious EB.
    Drug Deliv; 2016 Nov; 24(1):181-187. PubMed ID: 28156162
    [Abstract] [Full Text] [Related]

  • 12. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
    Joseph E, Reddi S, Rinwa V, Balwani G, Saha R.
    Eur J Pharm Sci; 2017 Jun 15; 104():315-325. PubMed ID: 28408348
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
    Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X.
    Int J Pharm; 2009 Jul 06; 376(1-2):176-85. PubMed ID: 19409463
    [Abstract] [Full Text] [Related]

  • 14. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B, Khunt D, Misra M, Padh H.
    Int J Biol Macromol; 2016 Aug 06; 89():206-18. PubMed ID: 27130654
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tri-block co-polymer nanocarriers for enhancement of oral delivery of felodipine: preparation, in vitro characterization and ex vivo permeation.
    Sayed S, Habib BA, Elsayed GM.
    J Liposome Res; 2018 Sep 06; 28(3):182-192. PubMed ID: 28480807
    [Abstract] [Full Text] [Related]

  • 17. Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier.
    Liu JS, Wang JH, Zhou J, Tang XH, Xu L, Shen T, Wu XY, Hong Z.
    Int J Nanomedicine; 2014 Sep 06; 9():3923-35. PubMed ID: 25152622
    [Abstract] [Full Text] [Related]

  • 18. Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation.
    Khallaf RA, Aboud HM, Sayed OM.
    J Liposome Res; 2020 Jun 06; 30(2):163-173. PubMed ID: 31039651
    [Abstract] [Full Text] [Related]

  • 19. Utilization of Polymeric Micelles as a Lucrative Platform for Efficient Brain Deposition of Olanzapine as an Antischizophrenic Drug via Intranasal Delivery.
    Abo El-Enin HA, Ahmed MF, Naguib IA, El-Far SW, Ghoneim MM, Alsalahat I, Abdel-Bar HM.
    Pharmaceuticals (Basel); 2022 Feb 18; 15(2):. PubMed ID: 35215361
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration.
    Patel RB, Patel MR, Bhatt KK, Patel BG, Gaikwad RV.
    Drug Deliv; 2016 Feb 18; 23(1):307-15. PubMed ID: 24845478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.